Journal of hepatocellular carcinoma · 2026
HepaKineticNet: Deep Learning of CT-Derived Intratumoral Heterogeneity for Overall Survival Prediction in BCLC Stage B-C Hepatocellular Carcinoma Treated with Locoregional Therapy Plus First-Line TKI and Anti-PD-1 Therapy.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Li Jinpeng, Bu Wenzhe, Hanming Xiaotian, Zhang Qianqian, Song Jinlong, Chen Wei
Аннотация
PURPOSE: To develop HepaKineticNet, a deep learning framework that models inter-phase kinetic dynamics on multi-phase contrast-enhanced CT (CECT) to generate intratumoral heterogeneity (ITH) maps, and to assess in an independent external cohort whether a clinical-radiomics fusion model improves overall survival (OS) prediction in BCLC stage B-C hepatocellular carcinoma (HCC) treated with locoregional therapy plus first-line TKI and anti-PD-1 agents.
PATIENTS AND METHODS: In this bi-institutional retrospective study, HepaKineticNet was developed using 359 patients from one institution (231 training, 128 validation) and evaluated in an independent external test cohort of 95 patients from a second institution. HepaKineticNet integrates a Spatial Kinetic Differential Attention module into an nnU-Net backbone, separately encoding arterial wash-in and delayed wash-out kinetics, with multiscale coefficient-of-variation self-supervision. Ten radiomics features (hierarchical filtering) and three clinical variables selected by LASSO-penalised Cox regression (10-fold cross-validation) were used to build clinical, radiomics, and fusion Cox models.
RESULTS: A total of 277 deaths occurred, 128 of them in the development cohort. Baseline characteristics were balanced (all P>0.05). In the external test cohort, the fusion model achieved a C-index of 0.713, exceeding the clinical model (0.651; P=0.012). Time-dependent AUCs at 1, 2, and 3 years were 0.760 (95%CI 0.651-0.864), 0.838 (95%CI 0.736-0.930), and 0.909 (95%CI 0.686-1.000), whereas those of the clinical model were 0.676, 0.742, and 0.772. Kaplan-Meier analysis showed median OS of 9.5 vs 19.0 months for high- vs low-risk strata (HR 3.02, 95%CI 1.86-4.91; P<0.001). Discrimination was consistent across ten prespecified subgroups.
CONCLUSION: HepaKineticNet-derived ITH maps encode kinetic and spatial information that modestly improves individualized OS prediction and risk stratification in this combination-therapy HCC population, and may provide a noninvasive decision-support adjunct pending prospective validation.
PATIENTS AND METHODS: In this bi-institutional retrospective study, HepaKineticNet was developed using 359 patients from one institution (231 training, 128 validation) and evaluated in an independent external test cohort of 95 patients from a second institution. HepaKineticNet integrates a Spatial Kinetic Differential Attention module into an nnU-Net backbone, separately encoding arterial wash-in and delayed wash-out kinetics, with multiscale coefficient-of-variation self-supervision. Ten radiomics features (hierarchical filtering) and three clinical variables selected by LASSO-penalised Cox regression (10-fold cross-validation) were used to build clinical, radiomics, and fusion Cox models.
RESULTS: A total of 277 deaths occurred, 128 of them in the development cohort. Baseline characteristics were balanced (all P>0.05). In the external test cohort, the fusion model achieved a C-index of 0.713, exceeding the clinical model (0.651; P=0.012). Time-dependent AUCs at 1, 2, and 3 years were 0.760 (95%CI 0.651-0.864), 0.838 (95%CI 0.736-0.930), and 0.909 (95%CI 0.686-1.000), whereas those of the clinical model were 0.676, 0.742, and 0.772. Kaplan-Meier analysis showed median OS of 9.5 vs 19.0 months for high- vs low-risk strata (HR 3.02, 95%CI 1.86-4.91; P<0.001). Discrimination was consistent across ten prespecified subgroups.
CONCLUSION: HepaKineticNet-derived ITH maps encode kinetic and spatial information that modestly improves individualized OS prediction and risk stratification in this combination-therapy HCC population, and may provide a noninvasive decision-support adjunct pending prospective validation.